Skip to main content

An optimistic view for quantifying mRNA in post-mortem human brain.

Preece P, Virley D J, Costandi M, Coombes R, Moss S J, Mudge A W, Jazin E, Cairns N J

Publication: Brain Res Mol Brain Rees (2003) • Vol 116 • Page 7PMID: 12941456View on PubMed

Purpose

The purpose of this paper was to determine if the confounding variables of postmortem interval (PMI), gender, age at death, and brain pH upset the quantitative order (relative expression) of the brain transcriptome as measured by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) of seven mRNA transcripts.

Conclusion

The authors conclude that, based on their assessment of 7 genes, mRNA degradation associated with brain pH, PMI, gender, or age at death is not random, and quantitative order is preserved within an individual although absolute levels may display robust differences between individuals.

Studies (1)

Purpose

The purpose of this study was to evaluate mRNA levels of beta-actin, GAPDH, cyclophilin, MAP2, NSE, APP 770, and GFAP in postmortem brain, and to investigate whether mRNA levels were influenced by patient age, gender, or diagnosis, PMI, or brain pH.

Summary of Findings

While relative mRNA expression was highly variable between individuals (by 1000-fold), relative expression of different transcripts within an individual were highly correlated. Thus, the quantitative order within an individual was preserved for both genders and diagnoses examined. The authors conclude that, based on their assessment of 7 genes, mRNA degradation associated with brain pH, PMI, gender, or age at death is not random, and quantitative order is preserved within an individual although absolute levels may display robust differences between individuals.
  • Biospecimens

    TissueBrain
  • Preservation Types

    Frozen
  • Diagnoses

    Alzheimer's Disease
    Not specified
    Autopsy
  • Platforms

    RNAElectrophoresis
    RNASpectrophotometry
    RNAReal-time qRT-PCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionDiagnosis/ patient condition
    Alzheimer's disease
    No diagnosis of Alzheimer's disease
    PreaquisitionPatient age
    41 - 91 years
    PreaquisitionPatient gender
    Female
    Male
    PreaquisitionPostmortem interval
    4 - 117 h
    Biospecimen Aliquots and ComponentspH
    Brain pH 5.8 - 7.2